Zacks Research Has Pessimistic View of Revvity Q4 Earnings

Revvity, Inc. (NYSE:RVTY - Free Report) - Research analysts at Zacks Research lowered their Q4 2025 EPS estimates for Revvity in a report released on Monday, April 14th. Zacks Research analyst R. Department now expects that the company will post earnings per share of $1.49 for the quarter, down from their previous forecast of $1.50. The consensus estimate for Revvity's current full-year earnings is $4.94 per share. Zacks Research also issued estimates for Revvity's Q3 2026 earnings at $1.44 EPS and Q4 2026 earnings at $1.56 EPS.

Several other research firms also recently commented on RVTY. KeyCorp upped their price target on shares of Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Wells Fargo & Company lowered their target price on shares of Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 17th. Robert W. Baird lowered their target price on Revvity from $141.00 to $127.00 and set an "outperform" rating on the stock in a report on Monday. Sanford C. Bernstein downgraded Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price objective on the stock. in a research report on Friday, January 10th. Finally, Barclays cut their target price on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research note on Thursday, April 10th. Four investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Revvity has an average rating of "Moderate Buy" and a consensus target price of $130.50.

Revvity Stock Performance

RVTY traded up $3.30 on Thursday, reaching $93.07. The company had a trading volume of 532,785 shares, compared to its average volume of 896,278. The stock has a market capitalization of $11.18 billion, a PE ratio of 42.12, a P/E/G ratio of 3.82 and a beta of 1.07. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. Revvity has a 1 year low of $88.53 and a 1 year high of $129.50. The stock has a 50-day moving average price of $106.34 and a 200-day moving average price of $113.76.

Revvity (NYSE:RVTY - Get Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $1.42 earnings per share for the quarter, beating analysts' consensus estimates of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same period in the previous year, the firm earned $1.25 EPS.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Victory Capital Management Inc. grew its position in shares of Revvity by 17.4% in the 4th quarter. Victory Capital Management Inc. now owns 70,250 shares of the company's stock worth $7,841,000 after acquiring an additional 10,390 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Revvity by 13.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 344,115 shares of the company's stock valued at $43,961,000 after buying an additional 41,497 shares during the period. Contravisory Investment Management Inc. grew its position in shares of Revvity by 1,715.9% during the 4th quarter. Contravisory Investment Management Inc. now owns 69,186 shares of the company's stock valued at $7,722,000 after buying an additional 65,376 shares during the last quarter. Janney Montgomery Scott LLC raised its stake in Revvity by 87.0% during the fourth quarter. Janney Montgomery Scott LLC now owns 7,891 shares of the company's stock worth $881,000 after acquiring an additional 3,672 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. boosted its stake in Revvity by 41.5% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 12,072 shares of the company's stock valued at $1,352,000 after acquiring an additional 3,542 shares during the period. 86.65% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Revvity

In other Revvity news, insider Joel S. Goldberg sold 15,170 shares of the company's stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the transaction, the insider now directly owns 33,400 shares of the company's stock, valued at $4,232,782. This represents a 31.23 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.68% of the stock is owned by corporate insiders.

Revvity Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be issued a dividend of $0.07 per share. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.30%. Revvity's payout ratio is currently 12.67%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.